||EPS - Basic
||Market Cap (m)
Revolymer Share Discussion Threads
Showing 76 to 99 of 100 messages
|Itaconix is becoming dominant,now the new name.-ITX.Might attract some US interest for a fund raise.|
|Not withstanding the possibility of further M&A.|
|I agree,bottom drawer, but markets are climbing a wall of worry at present so who knows.|
|Yes, they have a string of patents that haven't even featured yet. Really like the prospects here but realise it's going to be a long term investment that's not without risks. Could need further funds before any sales traction can be established.|
|Itaconix looks like an astute buy and looks to dominate the entity with plenty to go for. GL.|
|Yes a bit of new info there, Expansion to keep up with demand stands out...|
|Good find battlebus, thanks.|
February 12. 2017 11:04PM
Stratham's polymer company Itaconix prepares for growth
STRATHAM — Itaconix Corp., a polymer company with ties to the University of New Hampshire, plans to double its staff, according to CEO and co-founder John Shaw.
Two new agreements with AkzoNobel and Croda Inc. mean the company is looking to hire at least eight new people for its team in Stratham, where polymers are produced and then sent throughout North America and Europe, Shaw said Thursday.
Polymers are used in laundry and automatic dishwashing detergents, and Itaconix will also produce a bio-based product that is soluble in water and does not leave any residual materials behind for odor removal in carpets and pet products.
“We have a lot of new products, and we’re finding people to collaborate with us to take them to market faster,” Shaw said about the agreements.
With AkzoNobel, Itaconix will contribute proprietary polymerization technology to turn itaconic acid obtained from sugars through fermentation into polymers.
Itaconix will work with Croda to grow and supply worldwide demand for ZINADOR, which is the odor removal additive.
Shaw said the company’s products are more environmentally friendly than traditionally used chemicals, both in their production and when released into the environment after use.
“It’s exciting to make those products safer,” Shaw said about the work that is being done at the Stratham facility. He is currently in Europe connecting with clients.
Shaw founded Itaconix in 2008 with Yvon Durant, the company’s chief technology officer. The company moved to Stratham in 2012, and is in the midst of completing a $1 million expansion within that facility to keep up with demand.
Durant worked as a professor for UNH before co-founding the company based on an idea he developed. Shaw gives Durant credit for much of the company’s success, and the duo pay it forward. They hire UNH graduates who study science and chemical engineering.|
|Has the potential to be much bigger a few years down the line imv.|
|Thanks battlebus2.I see similarities with another mutual holding ZTF.|
|Welcome onboard Geraldus. Indeed.|
|Also been watching for sub 30p but bought some today as looking very interesting on the recent newsflow.Woodford in these at higher levels and plenty of director buying at 34p.Some great niche tech but may yet have to pass the hat around. GLA.|
|Been watching for a while.Bought today on that second good RNS.atb|
|mm's just like to move the spread robbing barstewards|
|Broker target 70p as far as I recall|
|Looks to be good news here today. Any broker notes or anything to help newbies get up to speed before that chart decides to take off?|
|just put another buy order in at 33p not been filled yet|
|Maybe a reason for that, we will see.|
|Two great pieces of news in the same week and it's ignored by the market.|
|Bought in recently also, albeit a small holding only - for the time being anyway.|
|Trade above the quote at 36.75 for 30k...|
|More director buying bodes well imv....|
|NED buys first shares......Revolymer (AIM: REVO) has been notified that on 5 October 2016 Dr James Barber, Non-Executive Director of the Company, purchased 45,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 32 pence per Ordinary Share.
Following this purchase, Dr Barber holds 45,000 Ordinary Shares, representing 0.06% of the Company's issued share capital.|